Canada· CA-DIN-01947931
DUVOID
A bethanechol product containing bethanechol chloride, registered in Canada by ENDO OPERATIONS LTD.. The same ATC class is registered in 9 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Bethanechol is registered in 9 of 19 countries.
Countries holding a registration under ATC N07AB02 (bethanechol), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 5 of them publish a price we can compare per daily dose
Bethanechol · ATC N07AB02
9 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Germany
- Japan
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- BETHANECHOL CHLORIDE
- Manufacturer
- ENDO OPERATIONS LTD.
- Country
- Canada (CA)
- ATC code
- N07AB02
- ATC class
- Bethanechol
- Defined daily dose
- 45 mg, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
38 interactions on record for bethanechol.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bethanechol · interactions on record
38 records
- 4 severe
- 31 moderate
- 3 info
Most severe, free to view
- BupropionN06AX12severe
- BupropionN07BA02severe
- IohexolV08AB02severe
- IopamidolV08AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bethanechol in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBethanechol ChlorideUpsher-Smith Laboratories, LLC
- SwitzerlandMyocholine-Glenwood 25 mg, TablettenCPS Cito Pharma Services GmbH
- United KingdomMyotonine 25mg tabletsGlenwood GmbH
- GermanyMyocholineGlenwood Gmbh
- FinlandMyocholine-Glenwood
- Japanベタネコール塩化物アルフレッサファーマ
- NorwayMyocholineGlenwood
- BelgiumMyocholine Glenwood 10 mgGlenwood
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Austria · Myocholine
- Belgium · Myocholine
- Cyprus · Myocholine
- Germany · Myocholine
- United Kingdom (Northern Ireland) · Bethanechol Chloride Infectopharm Arzneimittel Und Consilium Gmbh
- Luxembourg · Myocholine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/52e08384-6484-4ae1-b860-e64c7d43616d GET /v1/drugs/52e08384-6484-4ae1-b860-e64c7d43616d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "01947931",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "N07AB02",
"schedule": [
"Prescription"
],
"drug_code": "12745",
"strengths": [
"25 MG"
],
"ahfs_class": null,
"substances": [
"BETHANECHOL CHLORIDE"
],
"product_categorization": null
}See everything about bethanechol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.